The main risk factors for pulmonary fibrosis post-COVID-19 identified in our study are increased ESR, CRP, LDH, duration of hospitalization, and the severity of pneumonia (characterized by several pulmonary lobes involved and the percent of interstitial pulmonary lesions). The gene discussed is ESR1; the disease is COVID-19.